ADVERTISEMENT

other value-based care improvements

Abstracts

Clinical Benefits and Commonly Reported Adverse Events and Their Associated Costs in Patients With Chronic Lymphocytic Leukemia Treated With Bruton Tyrosine Kinase Inhibitors in First-Line and Relapsed/Refractory Settings

08/23/2024

Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...

Ibrutinib, acalabrutinib, and zanubrutinib are Bruton tyrosine kinase inhibitors (BTKis) approved for treatment of chronic lymphocytic leukemia (CLL). In this study, researchers used data from package inserts, clinical trials, and real-world...

Ibrutinib, acalabrutinib, and...

08/23/2024

Journal of Clinical Pathways

Abstracts

Building an Episode of Care to Reduce Time to Treatment

08/23/2024

When previously identifying causes of delay in cancer treatment, existing workﬂows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...

When previously identifying causes of delay in cancer treatment, existing workﬂows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...

When previously identifying...

08/23/2024

Journal of Clinical Pathways

Abstracts

Building an Episode of Care to Reduce Time to Treatment

08/23/2024

When previously identifying causes of delay in cancer treatment, existing workﬂows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...

When previously identifying causes of delay in cancer treatment, existing workﬂows often did not provide consistent timelines estimated for providers to diagnose and treat patients. To reduce time to treatment, researchers employed a pilot...

When previously identifying...

08/23/2024

Cancer Care Business Exchange

Featured Webinar

Implementing ERAS Protocols Throughout Patient Peri-Op Journey: Reductions in Complications

Advertisement

Advertisement

Advertisement

Upcoming Events

September 18 ⁠–⁠ September 20

September 20 ⁠–⁠ September 22

September 21 ⁠–⁠ September 22

AMP Europe

September 30 ⁠–⁠ October 2

October 1 ⁠–⁠ October 2

October 2 ⁠–⁠ October 5

October 5 ⁠–⁠ October 6

October 14 ⁠–⁠ October 16

October 16 ⁠–⁠ October 19

October 19 ⁠–⁠ October 20

See Full Calendar

Advertisement

Advertisement